Study period | ||||||
---|---|---|---|---|---|---|
Enrollment | Allocation | Postallocation | Closeout | |||
Time point | −12 mo | 0 | 0 | 6 mo | 12 mo | 16 mo |
Enrollment | ||||||
Eligibility screen | X | |||||
Informed consent | X | |||||
Allocation | X | |||||
Intervention arm | ||||||
Provider-mediated phase |
| |||||
Patient-mediated phase |
| |||||
Control arm | ||||||
Provider-mediated phase |
| |||||
Patient-mediated phase |
| |||||
Assessments | ||||||
Baseline variables | X | |||||
Providers: age, sex, duration in practice, practice load, remuneration plan, academic or community practice, rural or urban practice, solo or group practice | ||||||
Patients: age, sex, ethnicity, age at diagnosis, comorbidities, smoking status, educational attainment, annual income | ||||||
Outcome variables | ||||||
Logs of all study processes to assess recruitment and retention |
| |||||
Website use statistics | X | |||||
Decisional conflict, diabetes distress, health-related quality of life, chronic illness care, intention to engage in IP-SDM | X | X | X | |||
Qualitative interviews | X |